Hsp90 ATPase activity that acts as a late cofactor of the Hsp90 complex (Panaretou et al., 2002; Wegele et al., 2004) . Wang et al., (2006) show that overexpression of Aha1 markedly destabilized ∆F508 CFTR, whereas its downregulation significantly improved stability, trafficking, and delivery of functional ∆F508 CFTR to the plasma membrane. Reduction of Aha1 protein levels decreased ∆F508 CFTR binding to Hsp90 but did not appear to induce cellular stress or alter the levels of other chaperones. These findings are surprising for several reasons. First, Aha1 enhances ∆F508 CFTR degradation, whereas it has been shown to promote activation of other Hsp90 clients (Wegele et al., 2004) . Second, the downregulation of p23 destabilized ∆F508 CFTR despite predictions that p23 downregulation should also decrease CFTR binding to Hsp90. Although several scenarios could be envisioned, these data suggest that Aha1 blocks CFTR-Hsp90 interactions in a manner very different from p23 and that the outcome depends on where in the Hsp90 pathway these cofactors act. If p23 facilitates client transfer from the Hsp70 to the Hsp90 system as has been proposed, then less CFTR would be transferred to Hsp90 when p23 levels were reduced. In contrast, a reduction in Aha1 might induce late release of CFTR from the mature Hsp90 complex, perhaps after a transport-permissive conformation is achieved. One intriguing possibility is that decreasing the levels of Aha1 allows ∆F508 CFTR increased time to bypass a proposed kinetic block in folding (Qu et al., 1997) . A detailed understanding of the temporal recruitment of these and other cochaperones will be needed in order to determine how the balance of Aha1 and Hsp90 cycling perturbs the folding environment to favor ∆F508 maturation.
What is clear from these studies is that maturation of at least some proteins that are prone to misfolding can be enhanced by manipulation of both the Hsp70 and Hsp90 chaperone systems. For the moment, Wang et al., (2006) have focused attention on an important decision point that likely involves the handoff of client proteins from Hsp40/70 to the Hsp90 folding complex. The next challenge will be to determine which of the many newly implicated components of this network can be targeted to promote maturation of specific cargos with little cost in terms of toxicity to the cell. Such a strategy might be used in therapies for diseases associated with protein misfolding, including cystic fibrosis.
The tumor-suppressor protein p53 is a key regulator of cell-cycle control, apoptosis, and genomic stability. The amount of p53 protein in a cell is normally limited by ubiquitin-dependent degradation. In this issue of Cell, Le Cam et al. (2006) reveal that p53 ubiquitination contributes to transcriptional activation rather than protein stability. These results may provide insight into how p53 can modulate diverse cellular processes such as growth arrest and apoptosis. Le Cam et al. (2006) occurs in response to stimuli such as DNA damage that normally result in stabilization of p53. This ubiquitination is promoted by the transcription factor E4F1, a zinc-finger protein of the GLI/Kruppel family implicated in regulation of adenoviral genes as well as cell proliferation and survival (Lee et al., 1987) . Given that E4F1 is a transcription factor with DNA-binding specificity, it is likely that the heterodimer p53/E4F1 recognizes select promoters, as shown for the promoter of the p21 gene. Le Cam et al. (2006) demonstrate that E4F1 facilitates p53 ubiquitination within the hinge region (amino acids 319-321), thereby attenuating p53 acetylation by the histone acetylase PCAF on lysine 320, which is associated with the activation of apoptosis genes by p53. Thus, ubiquitination that affects the pattern of p53 acetylation may be part of the mechanism underlying the selectivity of p53 transcriptional activity. These observations raise the possibility that p53 stability and activity are regulated by its associated ligases and deubiquitinating enzymes, which are expected to affect the length and topology of this ubiquitination process over time (that is, before, during, and after transcriptional activation by p53). Ubiquitination of p53 is also expected to mark it for degradation upon completion of its function as a transcriptional activator, as demonstrated for other transcription factors including ATF2 and SREBP (Fuchs and Ronai, 1999; Punga et al., 2006) . Although the newly ascribed role of p53 ubiquitination is consistent with current understanding of ubiquitination in transcriptional control (Collins and Tansey, 2006) , there are a number of questions that need to be addressed. For example, how much of the total p53 bound to the p21 promoter is ubiquitinated at different phases during the p53-dependent activation of p21 transcription? Which ligases contribute to these However, the functional domains within E4F1 that may be responsible for its ligase activity are limited to a single IR region that is also found in the SUMO ligase RanBP2. Thus, it is possible that E4F1 promotes p53 ubiquitination by recruiting a bona fide E3 ligase that associates with the p53/E4F1 complex. In support of this possibility, a growing number of p53-related ubiquitin ligases have been found to be associated with the promoters of p53 target genes. For example, E6-AP is required for transactivation of the HPV-E6 gene (Liu et al., 2005) . Additionally, Mdm2 (the mouse homolog of Hdm2) is found within the chromatin-bound p21 promoter before, but not after, DNA damage (White et al., 2006) . The latter finding raises the possibility that degradation of p53 by Mdm2 may take place at the promoters of p53 target genes. Other Mdm2-and p53-associated proteins implicated in transcriptional regulation of p53 target genes are found at such promoters, including hnRNP-K and pVHL. hnRNP-K 
p53 Ubiquitination at the Promoters of Its Target Genes
Accumulating evidence points to the presence of Mdm2 and its associated proteins on promoters of p53 target genes prior to DNA damage. This raises the possibility that some of p53 may be degraded on the promoters to which it is bound (compare bottom panels). Following DNA damage, Mdm2 dissociates from p53 and the promoter, enabling p53-mediated transcription-prompted by ubiquitination of p53 in the presence of E4F1-to proceed (Le Cam et al., 2006) . As other ligases (such as pVHL) are present within this complex, transcription controlled by p53 ubiquitination may be mediated by several associated ligases. This model also stipulates that different promoters may be subject to different types of regulation, dictated by the recruitment of different p53 ligases and associated transcription factors.
is found on the promoters of p53-responsive genes and is targeted by Mdm2 for degradation before, but not after, DNA damage (Moumen et al., 2005) . pVHL-implicated in regulation of HIF1α-was recently shown to attenuate ubiquitination of p53 by Mdm2 while inducing the interaction between p53 and the acetylase p300/CBP that results in increased p53 acetylation and transcriptional activities (Roe et al., 2006) . Thus, one may envision that changes in the p53 complex before and after DNA damage may switch the ligases that subject p53 to different modes of ubiquitination. Along these lines, one wonders how much of p53 degradation prior to DNA damage is occurring at the promoter sites (compare left and right panels in Figure 1 ) and whether different promoters are occupied by distinct p53 ligases, as well as specific p53 heterodimeric partners. Additional posttranslational modifications, including acetylation and sumoylation, are expected to affect p53 localization and its assembly on promoters of its target genes.
Although E4F1 is shown by Le Cam et al. (2006) to affect activation of the p21 promoter, it is likely that selectivity is acquired by the heterodimeric complex of transcription factors rather than the actual ubiquitination per se. Thus, one may expect a plethora of transcription factors and ubiquitin ligases to engage p53 activities on target gene promoters that elicit each of p53's distinct functions. This is the first report to link p53 ubiquitination with transcriptional activation. However recent studies have shown that p53 ubiquitination affects its localization and, consequently, its activity. WWP1, a HECT-domain ligase, causes p53 ubiquitination but limits its transcriptional activation by exporting p53 to the cytosol . Ubc13, a ubiquitin-conjugating enzyme involved in noncanonical ubiquitination, was shown to recruit p53 to polysomes and prevent p53 from forming a tetramer, thereby affecting its localization and transcriptional activity . One expects that more ligases will be found to affect the diverse functions of p53 activities by contributing to each of the steps required for p53 availability, localization, and selective activity. Given that most p53 studies have not been confined to chromatin-bound material, further analysis of p53 within this fraction may help to clarify key mechanisms engaged in the regulation of p53 availability and activity.
